Mel Sorensen
CIK 1444783 · President and CEO · last filed 2025-11-24
Mel Sorensen is a President and CEO who has filed 9 SEC Form 4 insider transactions across 1 company since 2020. Across all open-market trades the lifetime net is +$168.1K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$168.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics, Inc. (GRTX) Delisted | President and CEO | 332,044 | $0.14 | $48.1K | $168.1K | 6 | 2023-03-14 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-24 | — | Sell (S) | −70,000 | -$1.4K | |
| 2025-05-05 | — | Grant (A) | — | $0 | |
| 2024-08-20 | — | Sell (S) | −67,015 | -$4.8K | |
| 2023-03-14 | Galera Therapeutics, Inc. (GRTX) Delisted | Buy (P) | +100,000 | $168.1K | EDGAR |
| 2023-02-28 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-30 | Galera Therapeutics, Inc. (GRTX) Delisted | Exer (M) | +217,015 | $235.5K | EDGAR |
| 2021-01-28 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |